Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1

Area of Science:

• Molecular Biology
• Cell Biology
• Epigenetics

Background:

• The biological outcomes of E2F-1 activity are diverse but not fully understood.
• E2F-1 is a key transcription factor regulating cell cycle progression and apoptosis.

Purpose of the Study:

• To elucidate the mechanisms governing differential E2F-1 biological outcomes.
• To investigate the role of residue-specific methylation by PRMT1 and PRMT5 in E2F-1 function.

Main Methods:

• Analysis of E2F-1 methylation by protein arginine methyltransferase 1 (PRMT1) and PRMT5.
• Assessing the functional consequences of specific methylation marks on E2F-1 activity, including apoptosis and proliferation.
• Investigating the interaction between E2F-1, cyclin A, and p100-TSN.

Main Results:

• PRMT1-mediated methylation of E2F-1 promotes apoptosis, while PRMT5-mediated methylation favors proliferation.
• PRMT1 methylation antagonizes PRMT5 methylation, and vice versa, establishing a reciprocal regulatory relationship.
• Cyclin A binding to E2F-1 inhibits PRMT1 methylation and enhances PRMT5 methylation, promoting cell cycle progression.
• The Tudor domain protein p100-TSN binds to symmetric methylation marks on E2F-1, downregulating its apoptotic activity.

Conclusions:

• Residue-specific methylation by PRMT1 and PRMT5 acts as a critical switch for E2F-1 function, dictating either apoptosis or proliferation.
• The interplay between methylation 'writers' (PRMT1, PRMT5) and 'readers' (p100-TSN) provides precise control over E2F-1 biological outcomes.
• This study reveals a novel layer of epigenetic regulation governing E2F-1 activity and its role in cellular fate decisions.